CancerDrs

Thyroid Cancer

Papillary, follicular, medullary, and anaplastic thyroid carcinomas. Most are highly curable; trials focus on advanced and recurrent disease.

98.4%
5-year relative survival
U.S. average across all stages
81
recruiting trials
Active in the U.S. right now
44,020
new diagnoses / year
You are not alone — roughly 121 people per day
51
median age at diagnosis
Most diagnoses occur in adults over age 50

Source: NCI SEER + ClinicalTrials.gov

Thyroid Cancer by the numbers (U.S.)

44,020
Estimated new cases (2025)
2,290
Estimated deaths (2025)
98.4%
5-year relative survival
51
Median age at diagnosis

Source: NCI SEER Cancer Stat Facts

Thyroid Cancer clinical trials →

81 actively recruiting trials across the U.S., with filters by state.

Second opinion for thyroid cancer →

Step-by-step for getting a virtual second opinion from a top cancer center.

NCI-designated cancer centers →

All 71 NCI cancer centers with hospital quality data and state browser.

Find a medical oncologist →

Licensed oncologists across every U.S. state, by specialty.

Financial aid resources →

Co-pay relief, drug patient-assistance, transportation, and lodging support.

Patient guides →

How to read a pathology report, questions to ask your oncologist, staging explained.

Also known as

papillary thyroid, follicular thyroid, medullary thyroid, anaplastic thyroid.

For deeper statistics

See the NCI SEER Cancer Stat Facts page: Thyroid Cancer on SEER →